Tonix Pharmaceuticals Holding Corp. reported preliminary operating results for Q1 2026, noting a net loss of approximately $40.8 million and cash reserves of $185.5 million as of April 30, 2026. The company anticipates that these resources will fund operations into Q2 2027.